1Sugimori C, Yamazaki H, Feng X, et al. Roles of DRB1 * 1501 and DRB1 * 1502 in the pathogenesis of aplastic anemia[ J]. Exp Hematol,2007,35 ( 1 ) : 13 - 20.
2Dufour C, Capasso M, Svahn J,et al. Homozygosis for (12)CA repeats in the first intron of human IFN-γ gene is significantly associated with the risk of aplastic anaemia in Caucasian population[ J]. Br J Haematol,2004,126 ( 5 ) :682 - 685.
3Peng J,Liu C,Zhu K,et al. The TNF2 allele is a risk. factor to severe aplastic anemia independent of HLA-DR [ J]. Hum Immunol, 2003,64 ( 9 ) : 896 - 901.
4Dufour C, Svahn J, Bacigalupo A, et al. Genetic polymorphisms of CYP3A4, GSTF1, GSTM1, GSTP1 and the risk of acquired idiopathic aplastic anemia in Caucasian Patients [ J ]. Haematologica,2005,90 ( 8 ) : 1027 - 1031.
5Dirksen U, Moghadam KA, Mambetova C, et al. Glutathione S transferase theta 1 gene ( GSTF1 ) null genotype is associated with an increased risk for acquired aplastic anemia in children [ J ]. Pediatr Res ,2004,55 ( 3 ) :466 - 471.
6Yamaguchi H, Calado RT, Ly H, et al. Mutation in TERT, the gene for telomerase reverse transcriptase, in aplastie anemia[ J]. N Engl J Med ,2005,352 (14) : 1413 - 1424.
7Savage SA, Calado RT, Xin ZT,et al. Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia [ J ]. Exp Hematol,2006,34 (5) :664 - 671.
8Risitano AM, Kook H, Zeng W, et al. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry [ J ]. Blood, 2002,100 ( 1 ) : 178 - 183.
9Zeng W, Kajigaya S, Chen G, et al. Transcript profile of CD4^+ and CD8^+ T cells from the bone marrow of acquired aplastic anemia patients[ J]. Exp Hematol,2004,32 ( 9 ) :806 - 814.
10Fan Y,Ge Y,Zhu H,et al. Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L[ J ]. Tissue Antigen ,2004 ,64 (3) : 257 - 263.
二级参考文献7
1Ruegg CL,Rajasekar S,Stein BS,et al.Degradation of CD4 following phorbol-induced internalization in human T lymphocytes.Evidence for distinct endocytic routing of CD4 and CD3.J Biol Chem,1992,267:18837-18843.
2Rostaing L,Tkaczuk J,Durand M,et al.Kinetics of intracytoplasmic Thl and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells.Cytometry,1999,35:318-328.
3Weiner HL.Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells.Immunol Rev,2001,182:207-214.
4Anderton SM.Peptide-based immunotherapy of autoimmunity:a path of puzzles,paradoxes and possibilities.Immunology,2001,104:367-376.
5Thomson CT,Kalergis AM,Sacchettini JC,et al.A structural difference limited to one residue of the antigenic peptide can profoundly altered biological outcome of the TCR peptide MHC class Ⅰ interaction.J Immunol,2001,166:3994-3997.
6Cochran JR,Cameron TO,Stem LJ.The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class Ⅱ oligomers.Immunity,2000,12:241-250.
7Dybedal I,Guan F,Borge OJ,et al.Transforming growth factor-beta 1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells.Blood,1997,90:3395-3403.
